Patents by Inventor Yuanfeng Xia

Yuanfeng Xia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF IAP INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20220175917
    Abstract: The present invention relates to a combination of a compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof which are used as an IAP inhibitor, and an immune checkpoint inhibitor; and use of the combination in the preparation of a cancer treatment drug.
    Type: Application
    Filed: March 6, 2020
    Publication date: June 9, 2022
    Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Yingchun LIU, Zhaobing XU, Shuhua HAN, Lihong HU, Charles Z. DING, Yuanfeng XIA, Haijun TONG, Lihua HE, Xin TIAN
  • VINYLPYRIDINE CARBOXAMIDE COMPOUND AS PD-L1 IMMUNOMODULATOR
    Publication number: 20220144806
    Abstract: Disclosed is a PD-L1 inhibitor, and specifically disclosed is a compound of formula (I) as a PD-L1 immunomodulator, a pharmaceutically acceptable salt or an isomer thereof.
    Type: Application
    Filed: February 3, 2020
    Publication date: May 12, 2022
    Applicant: ShanghaiFosunPharmaceuticalIndustrialDevelopmentCo.,
    Inventors: Yang Zhang, Yuanfeng Xia, Zhengxia Chen, Meibi Dai, Deheng Sun, Jian Zuo, Jian Li, Shuhui Chen
  • FLUOROVINYLBENZAMIDE COMPOUND AS PD-L1 IMMUNOMODULATOR
    Publication number: 20220119368
    Abstract: The present invention relates to a PD-L1 immunomodulator, and specifically discloses a compound of formula (I) as a PD-L1 immunomodulator, a pharmaceutically acceptable salt or an isomer thereof.
    Type: Application
    Filed: February 3, 2020
    Publication date: April 21, 2022
    Applicant: ShanghaiFosunPharmaceuticalIndustrialDevelopmentCo.,Ltd
    Inventors: Yang Zhang, Yuanfeng Xia, Deheng Sun, Jian Zuo, Zhengxia Chen, Meibi Dai, Jian Li, Shuhui Chen